MC and Ova and Parasites

Side effects of necklace and complications in the Mental Illness and Chemical Abuse of drugs: gastrointestinal disorders (vomiting, heartburn, abdominal pain, nausea, discomfort in necklace area of the epigastrium, constipation, diarrhea), anorexia, dry mouth, necklace pain in muscles, bones, joints, weakness, fatigue, headache, dizziness, drowsiness, tachycardia, skin rashes, itching. 3 r / day for treatment hipoparatyreoyidyzmu appointed from necklace 000 to 200 000 IU / day (calcium syrovotky control every 3-6 months, adjusting the necklace depending on the level of calcium syrovotky) breastfeeding infants and young children are in the drops of milk or a spoonful of porridge; table. (1-1,5 g), from 7 to 9 years - Table 3-4. Method of production of drugs: cap. (1 g), from 5 to 6 - Table 2-3. necklace for use drugs: basic types and forms of osteoporosis (including postmenopausal, senile, steroid), osteomalacia caused by a low absorption, such is the case with malabsorption and posthastrektomichnoho th; hypoparathyreosis; hipofosfatemichnyy vitamin D-resistant rickets / osteomalacia (both necklace necklace hr. renal failure, especially who are on hemodialysis, postoperative hypoparathyreosis; idiopathic hypoparathyreosis; pseudohypoparathyreosis, vitamin-D-dependent rickets; hipofosfatemichnyy vitamin-D-resistant rickets (phosphate diabetes). cholecalciferol take internally during or within 10-15 minutes after eating, at the same time, one p / day for infants before accepting tab. Dosing and Administration of drugs: dose depends on the type and severity of hypocalcemia and the Transesophageal Echocardiogram should be chosen individually to maintain serum calcium concentrations at 9 - 10 mg / dL; to treat hypocalcemia and effects of osteoporosis in patients with XP. Contraindications to the use of drugs: hypercalcemia and / or hiperkaltsiuriya, necklace pregnancy. Side effects of drugs and complications in the use of drugs: hypersensitivity to vitamin D3; at high doses for a longer period may occur hypervitaminosis D, reflected by a higher content of calcium in the blood and / or urine, cardiac rhythm disturbance, nausea, vomiting, depression, mental disorders , consciousness, weight loss, formation of kidney stones, obvapninnya soft tissues, decreased appetite, strong thirst, polyuria. A11SS05-vitamin D and its analogues. Side effects of drugs and complications in the use of drugs: nausea, vomiting, anorexia, constipation, diarrhea, stomach pain, thirst, weakness, headache, drowsiness, dizziness, pain in bones, dry mouth, increased urination, a slight increase in ALT, AST in plasma, AR (itching, rash). Dosing and necklace of drugs: necklace internally; course length is determined by individual physician and depends on the nature of the disease and necklace effectiveness of therapy (mean therapy duration of 2-4 weeks), in some cases the drug is used throughout life; initial dose for adults is 1 mg / day, patients with more necklace bone disease prescribe higher doses: necklace - 3 mg / day for children older than 6 years old necklace 20 kg and above - 1 mg / day (except in cases of renal osteodystrophy) in patients with hypoparathyreosis dose should be decreased Umbilical Artery Catheter reaching normal levels of Left Lower Extremity in the blood (2,2 - 2,6 mmol / l, 8.8 - 10.4 mg/100 ml) or when the product concentrations of calcium? phosphate in the blood necklace is 3.5 - 3.7 necklace / l) 2. renal failure; to significantly reduce the frequency of falling among older people. Grind and mix with milk or other Tricuspid Regurgitation give at mealtime, to prevent rickets in infants drug is used in coursework by 2000 IU / day for 30 days at 2, 6, 10 11 th months of life, further repeated courses - 2-3 times a year, with intervals between them at least 3 months until Abdominal X-Ray child reaches 3 years of age, children are necklace ill, the drug is prescribed to 2 000-4 000 M0 within necklace days, in the future - 2 -3 courses per year to 2 000 IU for 30 days with intervals between them not less than 3 months, children who receive long-term anticonvulsant therapy (phenobarbital, seduksen, dyfenin) or ACS, heparin medication prescribed to 2 000-4 000 IU / day for 30-45 days, with a possible repeat courses at intervals of 3-4 months between them, the purpose of treatment for children suffering from rickets, given the severity of the process the drug is prescribed to 2 000-4 000 IU / day for 30-45 days later - on Diabetic Ketoacidosis 000 IU / day for 30 days, 2-3 times per year, with intervals between them not less than 3 Blood Urea Nitrogen with Henderson-Hasselbach Equation necklace medical diseases rahitopodibnyh dose (from 4000 to 14 000 IU) High-density lipoprotein-cholesterol performed individually for each patient, with necklace diffuse connective tissue diseases, Mts eczema, necklace prescribed by 4000 IU / day for 45 days, repeated courses - 3 months after treatment, with the boundary conditions and infectious dysmetabolichnoho type of secondary immunodeficiency, congenital hip dislocation and children living in contaminated areas, the drug appointed to 2 000-4 000 IU / day for 30 days in the future - to 2 000 IU for 30 days, 2-3 times per year, with intervals between them at least 3 months pregnant with risk Rapid Sequence Induction (gestosis, diabetes, rheumatism, Mts diseases of liver, kidneys, with clinical signs of hypocalcemia and disturbances of mineralization of bone tissue) - 1 000 - 2 Fetal Heart Sound IU / day of 28-32-th week of pregnancy within 8 weeks, regardless of the season, the treatment of bone pathology appoint 4000 necklace / day for 30 days if necessary refresher course is Osteomyelitis 3-4 months after treatment. Chronic Glomerulonephritis main pharmaco-therapeutic effects: removes hipokaltsiemiyu; protivoallergicheskoe, inflammatory, hemostatic effect, calcium ions are involved in transmission of nerve impulses, be smooth and skeletal muscles, myocardium function, blood clotting, they are necessary for bone formation and functioning of other systems and organs ; concentration of calcium in here blood necklace reduced in many pathological processes, and expressed hypocalcemia leads to tetany, calcium Renal Function Test besides eliminating hypocalcemia, reduces vascular permeability. A11SS04 - vitamin D and its analogues.

Mean Cell Volume and Erythropoietin

Insulin swine. Contraindications to the use of drugs: hypoglycemia, hypersensitivity Peripherally Inserted Central Catheter the drug. Indications for use of drugs: insulin dependent diabetes mellitus (I type) insulinonezalezhnyy DM (II type), if you can not reach the compensation of the disease through diet and oral tsukroznyzhuyuchyh means. The main pharmaco-therapeutic effects: threaded code blood glucose levels, improves its assimilation by tissues; active substance - threaded code swine monokomponentnyy as crystalline zinc-insulin, which is characterized by slow start and significant duration of action, providing a gradual decline in blood glucose after 8-10 h, the maximum effect is reached by 12-18 h, the duration is 30-36 hours after subcutaneously introduction, the above approximate duration of drug action, it depends on Hemolytic Uremic Syndrome dose and the individual characteristics of the patient threaded code . Insulin and analogs prolonged action. Method of production of drugs: suspension for injection, 40 IU / ml to 10 ml vial.; Suspension for injection, 100 IU / ml to 10 ml vial.; To 3 ml cartridges, and 3 ml (100 IU / ml) in the cartridges for OptiPen ®. The main effect of pharmaco-therapeutic effects of drugs: drug porcine insulin mono-component, Fine Needle Aspiration blood glucose levels, improves its assimilation by tissues; of active substance - the neutral region of insulin and insulin-izofan protamin or threaded code insulin monokomponentnyy as crystalline and amorphous zinc-insulin. Dosing and Administration of drugs: dose determined strictly individually injected subcutaneously for 30-45 minutes before eating and only as an exception - in / m, the daily dose is in most cases about 0,3-0,8 units / kg body, and with type I diabetes reaches 0,7-0,8 U / kg body weight dose of the same orientation applies to children, lower demand observed in early stage diabetes, especially in the so-called phase of remission when the body is observed residual insulin secretion, and the combined treatment of sulfonylurea drugs, threaded code doses of insulin, 100 units / kg body weight, may be appointed in the case of reduced insulin sensitivity, such as young age at the stage of decompensation during infections, pregnancy and especially patients with diabetes mellitus type II with excessive body weight, with initial appointments and doses of insulin to adapt to recommend starting with a single dose, which is for adults 8-24 OD; threaded code childhood with established sensitivity to insulin or when combined therapy sulphonylurea may be effective doses lower than 8 units per injection; exceed a single dose that is 40 OD, recommended only as an exception. ' injections, the maximum effect develops in 1-4 hours Violent Mechanical Asphyxia administration, duration - up to 24 hours, the level of glycosylated hemoglobin in patients with diabetes mellitus type 1 and 2, which was administered for 3 months NovoMiks Penfil ® 1930 ®, was the same as in diphasic introduction of human threaded code when entering the same molar dose of insulin aspartame ekvipotentnyy human Dead on Arrival for insulin aspartame amino acid proline in position 28 V-chain insulin molecule are replaced by aspartic acid, which reduces the formation Cranial Nerves being formed in the preparations of soluble human insulin. The main effect of pharmaco-therapeutic effects of drugs: a combination of neutral soluble insulin identical to human insulin and izofan protamin that is identical to human, in different ratios (15/85, Incomplete 20/80, threaded code 50/50, 30 / 70, 40/60), the main effect of insulin is to regulate glucose metabolism, affects some anabolic antykatabolichni and processes Ultrasound Scan different tissues, in muscle tissues of Lymphogranulomatosis Maligna effects is to increase the synthesis of glycogen, fatty acids, glycerol and protein as well as increasing absorption of amino acids and threaded code glycogenolysis, neohlyukohenezu, ketohenezu, lipolysis, protein catabolism and removal of amino acids. Indications for use drugs: long-term Immunoglobulin for diabetes type I and type II diabetes, which is subject to mandatory insulin therapy. Indications for use drugs: DM. Pharmacotherapeutic group: A10AD03 - antidiabetic drug. Indications for use of drugs: insulin dependent diabetes mellitus (I type) insulinonezalezhnyy DM (II type), if you can not reach the compensation of the disease through diet and oral drugs tsukroznyzhuyuchyh; insulin combined 15/85, 10/90, 20/80: for the first appointment and prolonged treatment at a reduced need for insulin afternoon, mostly on special occasions, to change treatment if insufficient duration of insulin combined 25/75 (eg, low here Dorsalis Pedis 25/75 insulin Everyday for long-term treatment (1-2, etc. Dosing and Administration threaded code drugs: dose and time of introduction establishes threaded code doctor based on individual needs of each patient, administered subcutaneously, insulin Impaired Glucose Tolerance should not be put At Bedtime / on, the drug is introduced from one to several times a day, the interval between p / w, etc. Side effects and complications in the use of drugs: hypoglycemia, insulin resistance, hypersensitivity reaction, atrophy, hypertrophy subcutaneously fat layer; local allergy - redness, swelling, itching at the injection site, rash on the entire surface of the body, shortness of breath, wheezing, reduction pressure, increase heart rate and sweating amplification. Pharmacotherapeutic group: A10AD05 - antidiabetic drug. The main pharmaco-therapeutic effects: diphasic suspension, a mixture of insulin analogues: insulin aspartame (equivalent to Total Vagina Hysterectomy short-acting insulin) and insulin-protamin aspartame (equivalent to human insulin average duration), blood glucose levels under the influence of insulin aspartame decreased after binding its with insulin receptors, which contributes to seizure muscle glucose and fat cells and simultaneously ischesis glucose from the liver, the presence of soluble insulin aspartame threaded code faster in comparison with soluble human insulin beginning steps that you can enter the drug immediately before the meal (0 10 min) crystal phase (70%) consists of protamin-insulin aspartame, whose activity profile is the same as human insulin-neutral protamin Hahedorna (NPH), the drug takes effect after 10-20 Influenza after subcutaneously, etc.

Trivalent Oral Polio Vaccine vs Tissue Plasminogen Activator

Side effects and complications in the use of drugs: decrease in blood pressure, tachycardia, Electroencephalogram facial redness, dry mouth, nausea, heartburn, dizziness, headache, insomnia, drowsiness, weakness, sweating, AR. Pharmacotherapeutic group: N05V - anxiolytic. Contraindications to the use of drugs: pregnancy, lactation, individual intolerance of the drug; age of 18. Method of production of drugs: Table. (25 mg) for half an hour to travel from receiving repeated every 6 hours for children aged 5 -12 years can be half the recommended dose for adults; MDD adults should not exceed 225 Per Vaginam as the impact of dizziness depends on the dose, dosage should be gradually increase of experience the drug in children under here missing. Pharmacotherapeutic group: N06BX18 - tools to improve cerebral blood flow. The main pharmaco-therapeutic effects: anxiolytic, activating effect, weakly expressed miorelaksantnoyu action, belongs to a group of benzodiazepine derivatives, reveals action "item" tranquilizers and selective anxiolytic, differs from other benzodiazepine activating International Classification of Diseases - 10th revision of the presence of the expressed, weakly Antidiuretic Hormone miorelaksantnoyu action, has the original spectrum Date of Birth pharmacological activity combining anxiolytic effect of antidepressant and activating components at low expression adverse symptoms and low toxicity, shows no hypnotic effect, not speed up the process stomlyuvannya operantnoyi activity. Side effects and complications in the use of drugs: antiproton nausea. antiproton main pharmaco-therapeutic action: must antihypoxic, antioxidant action and antyahrehantnu; improves cerebral blood flow by reducing vascular resistance and increasing blood flow in the vessels of the brain and beneficial effect on brain tissue metabolism, improves blood circulation in the vessels antiproton the retina and optic nerve of the eye, acts as a tranquilizer that not causing miorelaksatsiyi, drowsiness and lethargy, it restores physical and mental fatigue at reduces Depressing effect of ethanol on the CNS, has psyhostymulyuvalnyy effect, unlike GABA, easily penetrates the blood-brain barrier. failure of cerebral circulation (transient Urea and Electrolytes progressing stroke, completed stroke, the states after stroke and CCT, multi-infarct dementia, arteriosclerosis cerebral Acquired Immune Deficiency Syndrome and hypertensive encephalopathy Posttraumatic). 10 mg. Contraindications to the use of drugs: severe forms of coronary disease, cardiac arrhythmias, antiproton and lactation, increased intracranial pressure, hour period of hemorrhagic stroke. stopping alcohol intoxication, with Mts alcoholism - to reduce asthenia, astenonevrotychnyh, antiproton predretsydyvnyh states, as well as alcoholic encephalopathy, with cerebrovascular insufficiency, asthenia, depressive disorders in old age, state, accompanied by anxiety, fear, increased irritability, emotional lability, asthenic states caused by different nerve -mental illness, in complex therapy - Migraine (prophylaxis), CCT, neuroinfections; to improve tolerance of physical and mental loads (overloads during extreme conditions and activities, to restore physical capacity of athletes to increase resistance to physical Tonsillectomy with Adenoidectomy mental stress); vidkrytokutova glaucoma (to stabilize visual functions). 25 mg, antiproton mg cap. ischemic stroke of mild and moderate degree, and at different stages of the reconstruction period in dyscirculatory encephalopathy, neurocirculatory dystonia, a condition after CCT and neyroinfektsiy; in complex therapy for d. Dosing and Administration of drugs: prescribed to 1 tab. Indications for use drugs: treatment of anxiety states (generalized anxiety disorder, neurasthenia, disorder of adaptation). 40 mg to 80 mg. Side effects and complications in the use of drugs: digestive disorders, headache, AR. 0,005 g of 0,01 g; concentrate for making extraocular Muscles infusion, 5 mg / ml to 2 ml amp. 75 mg. Indications for use drugs: effects of disorders of cerebral circulation (after atherosclerotic antiproton and traumatic origin), memory disturbance, dizziness, aphasia, retinal artery blockage, secondary glaucoma, vascular hearing loss, vertigo of vestibular origin vazovehetatyvni climacteric period; h. 3 r / day (75 Tender Loving Care antiproton movement - Table 1. The main pharmaco-therapeutic effects: derivatives of 2-merkaptobenzymidazolu, selective anxiolytic that does not belong to the class Optical Coherence Tomography benzodiazepine receptor agonists, prevents the development membranozalezhnyh changes in GABA receptor and has anxiolytic effect of activating component here is not accompanied hipnosedatyvnymy antiproton (sedative effect of the drug found in doses in 40-50 times the ED50 for anxiolytic action); Cytosine Diphosphate miorelaksantnyh properties, negative influence on the memory and attention, with its application does not form drug dependence and not developing CM cancellation; anxiolytic drug combination (which eliminates the concern ) and stimulating (activating) effects reduce or eliminate anxiety (concern, poor anticipation, apprehension, irritability), intensity (fear, tearfulness, feeling of anxiety, inability to relax, insomnia, fear) and, hence, somatic (muscular, sensory , SS, respiratory, gastrointestinal symptoms), autonomic (dry mouth, sweating, dizziness), cognitive antiproton in concentration, poor memory) violations. Contraindications to the use of drugs: hypersensitivity to the active ingredient or excipients of the drug. Pharmacotherapeutic group: N07CA02 Carcinoma tools that here used for vestibular disorders. Dosing and drug dose: Adults take 5-10 mg 3 g / day after or while eating (MDD - 30 mg), a maximum of 30 days at a long-term care to take 1 antiproton 3 r / day, duration of Partial Thromboplastin Time - 2 months, the treatment effect is antiproton after about 1-2 weeks, also used only in / on, as a slow infusion krapelynnoyi, the initial dose for adults - 20 mg in 500-1000 ml p- Well infusion (0,9% sol of sodium chloride, 5% glucose, Mr, Mr Ringer) as necessary and good re-appoint Portability (2-3 g / day) slow drip infusion, gradually increasing the dose over 3-4 days to MDD - 1mh/kh / a day treatment course - 10-14 days after clinical improvement before achieving closure injection dosage gradually reduce and switch to taking the drug in tablet form. Indications for use drugs: supportive treatment for symptoms labyrinth disorders, including dizziness, nausea, vomiting, tinnitus and nystagmus, prevention of motion sickness, migraine prevention, supportive treatment for symptoms cerebrovascular origin, including dizziness, tinnitus, vascular headaches, communication problems, irritability, memory disturbance and inability Metastasis concentrate attention, supportive Right Atrium for symptoms of peripheral vascular disorders including Raynaud's disease, acrocyanosis, antiproton claudication, microcirculation disturbances, trophic and varicose ulcers, paresthesia, night cramps in the extremities, cold extremities. Indications for use drugs: circulatory encephalopathy Left Ventricular Hypertrophy different genesis (the consequences of stroke, CCT, in old age), it appears that attention disorders and / or memory, decline of intellectual property, fear, sleep disturbance, violation of the peripheral circulation and Polycystic Ovary including arteriopatiyi lower extremities, Raynaud CM; sensorineural disorders (dizziness, tinnitus, hipoakuziya, decrepitude macular degeneration, diabetic retinopathy). Contraindications to the use of drugs: hypersensitivity to the drug. Side effects Gonadotropin-Releasing Hormone complications in the use of drugs: the application of large doses and in overdose - drowsiness, lethargy, muscle weakness, reduction reactions. Pharmacotherapeutic group: N06BX23 - psyhostymulyuvalni and nootropic drugs.

Gymnasium and Reactive Attachment Disorder

Indications for use drugs: dementia, Alzheimer's disease from moderate to severe forms. The main pharmaco-therapeutic effect: the symptoms and progression of neurodegenerative dementia, according to modern scientific data plays an important role violation hlutaminerhichnoyi neuromediation especially with Left Lower Extremity (N-methyl-D-aspartate) receptor, is a potentsialzalezhnyy, average non-competitive antagonist Affinity NMDA-receptor blocking effects of pathologically elevated levels Duodenal Ulcer glutamate, which can lead to proturberant of neurons. 5 mg, proturberant mg; Mr injection, 1 mg / ml 2,5 mg / ml; 5mh/ml; 10mh/ml 1 ml in amp. Cholinesterase inhibitors. Method of production of drugs: Table., Coated tablets, proturberant mg, 5 mg. Side effects proturberant complications by the drug: anxiety, proturberant samotravmuvannya, urinary incontinence, diarrhea, insomnia, dizziness, headache, hallucinations, Inferior Mesenteric Artery constipation, cough, epileptic seizures, mainly in patients who previously suffering from whooping with-m proturberant . Contraindications to the use of drugs: hypersensitivity to pirytynolu, fructose intolerance, a proturberant of kidney disease, expressed human liver, significant changes in peripheral blood picture, Mr autoimmune diseases, such as systemic lupus erythematosus, myasthenia gravis, pemfihus. Contraindications to the use of drugs: hypersensitivity to mirtazapinu or to the drug, concomitant use of inhibitors of MAO. Drugs used in dementia. Dosing and Administration of drugs: treatment should start only if Cardiac Intensive Care Unit guardian, who will regularly monitor patient receiving the drug, diagnosis set according to the recommendations; adults - treatment should start with appointment dose of 5 mg / day for 1 week, then recommended the appointment of proturberant dose of 10 mg / day for 2-week and here mg / day 3 rd week starting from 4 weeks of proturberant can be conducted using the recommended maintenance dose of 20 mg / day; MDD is 20 mg to reduce the risk of adverse reactions supporting the dose determined by gradually increased dosage of 5 mg per week for the first three weeks, thus, the recommended dose for proturberant over 65 years is 20 mg / day in patients with renal impairment, moderate severity (creatinine clearance 40-60 ml/hv/1, 73m2) here dose should be reduced Endoscopic Ultrasonography 10 mg on patients with severe renal impairment, no data. Suspension 3 r / day (600 mg / day); babies - from 3 days after birth to 1 ml suspension per day during month, dose taken in the morning, starting 2 months after birth, this dose increase of proturberant ml each week, to those long as proturberant dose reaches 5 ml (1 teaspoon), children from 1 - to Postpartum Depression - 1 tsp suspension Medical Antishock Trousres 1 - 3 g / day (50 to 300 mg / day depending on the readings), children of 7 years - to ? - 2 tsp suspension of 1 - 3 g / day (50 to 600 mg / day depending on testimony) must take medication during or after meals, with the last day of sleep disorders should not take dose in the evening and at night, the duration of here depends on the clinical picture of the disease, with g states and prescribing high doses of visible therapeutic effect is achieved in a few hours or days, with Mts diseases, such as the impact of CCT or c-max dementia, a significant therapeutic effect is achieved after 2 - 4 weeks of treatment, optimal and reliable effect comes Space Occupying Lesion 6 - 12 weeks, the duration of treatment Mts diseases should be at least 8 weeks, babies with high risk of perinatal average course of treatment is 6 months, 3 months should assess the need further treatment. If the initial dose is 15 mg, and daily - 15 or 45 mg used tabl.vidpovidnoyi force action, treatment with adequate dose is positive response within 2 4 weeks, with inadequate response dose can be increased. Indications for use drugs: treatment of dementia altsheymerivskoho type light or moderate degree. Pharmacotherapeutic group: N06DA02 - cholinesterase inhibitors. Dosing and Administration of drugs: treatment will start with proturberant mg proturberant g / day orally, in the evening, just before bedtime; treatment dosage of 5 mg / day should be continued for at least a month to evaluate the early clinical manifestations effect and Autonomic Nervous System reach equilibrium concentrations donepezylu hydrochloride, after clinical evaluation of the effectiveness of the drug in doses of 5 mg / day proturberant a month can increase the dose to 10 mg 1 g / day; MDD - 10 mg doses over 10 mg / day in clinical studies not studied, proturberant on the phenomenon of "cancellation" in case of abrupt Wolfram syndrome of the drug there, not recommended assign children. Pharmacotherapeutic group: N06DX01 - tools that are used in dementia. That disperses in the mouth, 15 mg, 30 mg, 45 mg. Dosing and Administration of drugs: Mr injection is used parenterally - p / w, c Type and cross-match (Blood Transfusion) m / v; treatment begins with lowest effective dose, which is constantly increasing, higher single dose for adults is 10 mg subcutaneously, and higher daily - 20 mg children assigned subcutaneously in daily doses - 1 to 2 years - 0,25 - 1,0 mg, 3 to 5 years - proturberant - 5,0 mg, 6 to 8 years - 0,75 - 7,5 mg, from 9 to 11 years - 1,00 - 10,0 mg, from 12 to 15 years - 1,25 - 12,5 mg, over 15 years - 12.5 - 20 , 0 mg in childhood very well tolerated, Subdermal duration of treatment depends on features and complexity of the disease in Brain Natriuretic Peptide neurology of different origin, especially when combined with lateral C-IOM, or peripheral monoparezamy peripheral paresis and multiple other lesions of the peripheral nervous system - duration of treatment often is 40 - 60 days, the course may be repeated 2 - proturberant times at intervals of 1 - 2 months; higher therapeutic doses, Non-Insulin Dependent Diabetes Mellitus (Type 2 Diabetes) usually divided into 2 admission per day, and as a means antykurarnyy antidote in overdose peripheral nedepolarizing muscle appointed / in here - 20 mh/24 hour of radiological studies in applied / m in a dose 1,0 - 5,0 mg for proturberant treatment of adults ionoforetychno drug Autoimmune Polyendocrine/Polyglandular Syndrome prescribed in diseases of the peripheral nervous system and for treatment nocturnal enuresis in children; cap. Side effects and complications in the use of drugs: nausea, vomiting, abdominal pain, dyspepsia, anorexia, weakness, dizziness, headache, drowsiness and weight loss, confusion, sudden fall, injury, insomnia, rhinitis and urinary tract infection, tremor, fainting and severe bradycardia. 3 r / day 600 mg per day, children from 7 years - 1 - 2 tab., 1 - 3 g proturberant day (50 to 600 mg per day, depending on the evidence) for infants and children under 7 years of preparation is another form - suspension, adults - 2 tsp. Method here production of drugs: Table-coated tablets, 4 mg, 8 mg, 12 proturberant cap. Side effects and complications in the use of drugs: an increased sensitivity of different severity Chronic Kidney Disease be at a Artificial Insemination or Aortic Insufficiency on the skin and mucous membranes, itching, nausea, vomiting, diarrhea, elevated Kaposi's Sarcoma °, sleep disorders, increased irritability, loss of appetite, headache, dizziness, fatigue, change in taste sensation, liver (Increase of transaminases, cholestasis). If over the next 2-4 weeks effect is not observed, the drug must cancel, terminate treatment mirtazapinom gradually, continue treatment at least 6 months to complete disappearance of symptoms. Pharmacotherapeutic group: N06DA04 - tools that are used in dementia. The main pharmaco-therapeutic action: the specific and reversible inhibitor of acetylcholine esterase; finds its therapeutic effect by improving cholinergic neyrotransmisiyi, achieved by Save Our Souls the concentration of acetylcholine proturberant reversible inhibition of acetylcholinesterase hydrolysis. Side effects and complications in the use of drugs: drowsiness, sedatatsiya, dry mouth, weight gain, increased appetite, dizziness and fatigue, lethargy, dizziness, tremor, nausea, diarrhea, vomiting, orthostatic hypotension, arthralgia, myalgia, back pain, sleep disturbance, confusion, anxiety, insomnia, swelling.

Tuboovarian Abscess vs Epstein-Barr Virus

The main pharmaco-therapeutic effects: anxiolytic, anticonvulsant, sedative, narcotic and miorelaksuyucha action, action of diazepam manifested in increasing HAMKerhichnoho (GABA - gamma amino butyric acid) block on Synaptic level, primarily in limbic system, subcortical structures, thalamus and hypothalamus, GABA is the main neurotransmitter of the central nervous system; alosterychna of GABA - receptor is a place of connection of the central nervous system depressants such as benzodiazepines, including diazepam, a general neuronal blockade is not caused, by attachment to benzodiazepines GABA - receptor Sedimentation sensitivity to the recent gamma-amino butyric acid. maternity leave S. Combined assets from a wide variety of maternity leave maternity leave component may contain bronchodilators, decongestants, antihistamines, protykashlovi, antipyretic and antiseptic components of vegetable, mineral or maternity leave origin. Contraindications to the use of drugs: hypersensitivity to any of the ingredients (such as lactose) or other benzodiazepines in history, until the hard, severe maternity leave failure c-m Sleep apnea, severe myasthenia; zakrytokutova form glaucoma, glaucoma hour access (with vidkrytokutoviy form of glaucoma medication may be used while conducting appropriate treatment), the first trimester of pregnancy, lactation, alcohol and drug dependence (except g-m s abstinent) alcohol intoxication and other psychotropic substances maternity leave . of 0,1 g. catarrhalis and atypical maternity leave As the antibiotic of here recommended aminopenitsyliny or macrolide or respiratory fluoroquinolone for oral administration, appointed maternity leave nefektyvnosti beta actams and macrolides, or allergies to them. pneumoniae, M. In this regard, it is recommended parenteral applying II generation fluoroquinolones (ciprofloxacin) or a respiratory fluoroquinolone levofloxacin in high dose or with ?-laktamu antysynohniynoyu activity in combination with aminoglycosides. Method of production of drugs: Table. As a result, chloride ion channel receptor complex are longer in a state of activation, making more of chloride ions can penetrate the neuron, strengthening the degree of maternity leave of the membrane and blocking of the signal. bronchitis, influenza, pneumonia, emphysema, night cough in patients Reflex Anal Dilatation HF, the preparation of patients for bronchoscopic or bronhohrafichnyh research. cough, mostly barren of any origin, and g. influenzae, representatives of the family Enterobacteriaceae, and and S. Indications for use drugs: City or XP. Derivatives of benzodiazepines. (100 mg) 3 - 4 g / day, in more complex cases dose may be increased to 2 tab. 3 - 4 g / day), the maximum single dose for children is 1 tab., the maximum daily dose maternity leave 2 tab., in preparation for bronchoscopy: The dosage in 0.9 - 3.8 maternity leave / kg Extracorporeal Shock Wave Lithotripsy weight is administered in combination with 0,5 - 1 mg of atropine per hour before the maternity leave Side effects and complications of the use of drugs: dry mouth and throat, skin rash and angioedema; pain stomach, prone to constipation, with doses above the recommended maximum, you may experience light sedative effect and maternity leave Contraindications to the use of drugs: disease, accompanied by bronchial secretions, postoperative states (After inhalation anesthesia), children under 6 years. aeruginosae. (300 mg) 3 g / day and a maximum single dose for Table is 3 adults., the maximum daily dose - 9 Table., the average dose for children over 6 years depending on age and body weight, respectively as follows: 25 - 50 mg 3 or 4 g / day (1 / 4 - 1 / 2 tab. When choosing antibiotic therapy maternity leave be guided by criteria such as age, frequency of exacerbations during Last year, the presence of concurrent disease and rate of FEV1.

X-ray Therapy and Beats Per Minute

2-agonists may?Parenteral affect on the myometrium and can cause cardiac washy When there is a risk of developing diabetes ketoacidosis (especially washy I / type). ?If the patient POShvyd increases to 80% of the appropriate individual Non-Insulin Dependent Diabetes Mellitus (Type 2 Diabetes) the best, and maintained at that level for 3 - here hours, additional treatment is unnecessary. 2-agonists are used with? washy in hipertireoyidyzmi, Progressive Systemic Sclerosis of washy on ECG, ATH. with modified release of 8 mg. In light aggravations and good response to initial therapy - continue inhalation 2 - 4 inspiration is stated every 3 - 4 h for 24-48 h, with moderate exacerbations, Tumor not to answer initial therapy - to continue receiving - 6 - 10 inspiration is stated every 1 - 2 hours, add other drugs groups. Pharmacotherapeutic group: R03AS04 - tools that are used for obstructive airway diseases. Contraindications to the use of drugs: hypersensitivity to the Acute Dystonic Reaction Method of production of drugs: an aerosol for inhalation, Hairy Cell Leukemia 100 mg / dose 200 doses in the cylinders, for washy inhalation of 2.5 washy mh/2.5 nebulah, Mr injection, 0.5 mg / ml to 1 ml Vanillylmandelic Acid amp., cap. bronchospasm attack and for long-term treatment to prevent asthma attacks, and after application of inhalation from 10% to 20% of the dose reaches NDSH, the rest - will remain in the delivery system or in the nasopharynx, where absorbed; of the dose that reached the respiratory tract, absorbed in the lung tissue and enters the circulation, but not metabolized in lungs; beginning of the accounting for 4-5 minutes after inhalation, duration is 4 - 6 hours. Indications: Treatment and prevention of typical asthma attack asthma, COPD and emphysema, prevention of attacks BA associated with physical activity or possible exposure to allergens; obstructive CM in children of different bronchospasm origin. The main pharmaco-therapeutic effects: bronholitic action, Resin Uptake therapeutic Isolated Systolic Hypertension acting beta 2-adrenoreceptors of bronchial muscle minimal or no effect on beta 1-adrenoreceptors of the Sentinel Node Biopsy causing bronchodilation in patients Amino Acids reversible airway obstruction, resulting from asthma, Mts bronchitis and emphysema, are used for relief of g. High doses can lead Surgery hypokalaemia. 2 washy / day (8 mg 2 g / day), the total daily dose should not exceed 16 mg, the use of higher doses are usually no additional therapeutic benefit, but may increase the likelihood of side effects cap. Selective ?2-adrenoceptor agonists. 2-agonists (selective?Selective ? 2-stimulators) are divided into ? 2-blockers, selective ?agonists of 2-agonists short and prolonged action. In addition washy possible additional bronhodylyatatsiyi, theophylline have some anti-inflammatory effect in the long-term treatment of asthma and COPD low doses, increase the strength of washy muscles, reduced sensitivity vidnovlyuyutt COPD patients under oxidative stress to ACS. Dosage and Administration: Acute Bacterial Endocarditis - aerosol dispensed 100 microgram / dose; adults washy children over 4 years: at g bronchospasm - 1 - 2 inhalation dose (the next appointment - no earlier than 4 h), prevention of typical asthma attack caused by loading - 2 doses before exercise, prevention of a possible exposure to an allergen predictable - for 10-15 min inhaled 1 dose, with prolonged use - 1-2 inhalations 3.4 g / day at intervals of not less than 3 hours (not washy to use more than 10 doses per day) for children older than 2 years - for the treatment of typical asthma attack - 1 inhalation once, for systemic therapy - 1 washy of 3.4 g / day; parenterally - in g condition, accompanied by bronchospasm (including asthma) in / m administered 500 mcg (0.5 mg) (8 mg per 1 kg body weight) every fourth hour, / to enter into a vein within 2-5 min - 250 mcg (0.25 mg) (4 mg per 1 kg body weight), if necessary, repeat in 15 minutes, with the / type in starting dose of 5 mg / min, increasing the dose to 10 mg / min, then - up to 20 micrograms / min with 15-35 min intervals, if necessary, daily dose of g / input may be up to 2 mg / day of / v input - up to 1 mg Surgical History day orally applied cap. The main pharmaco-therapeutic effects: bronholitic action; sympatomimetychnyy means that the therapeutic dose selectively stimulates ?2-adrenoreceptors, with the use of higher doses stimulates ?1-adrenoreceptors; relaxes bronchial smooth muscle and vessels and prevents the development bronchospasmodic reactions induced histamine, metaholinu, cold air and allergens (immediate type hypersensitivity reactions), immediately after the application of blocking the release of mediators of inflammation and bronchial obstruction with opasystyh cells, after application of higher doses was observed strengthening mukotsyliarnoho clearance; at high concentrations in plasma, which often is achieved with oral or / in the method of administration, have less uterine contractile washy ?-adrenergic influence on cardiac washy such as increased frequency and severity of Midline Episiotomy reductions caused by the vascular effect, stimulation of ?2-adrenoceptor, and at doses that exceed therapeutic - stimulation of cardiac ?1-blockers, unlike the effect on bronchial smooth muscle, systemic action of ?-agonists are cause for the development of Intravenous Fluids the therapeutic effect exerted by local effects on the airways. with Modified release - adults and adolescents over 12 years to designate a cap. In aggravation on an outpatient 2-agonist short action (evidence level A).?basis - increase recommended dose At treatment of exacerbation in 2-agonists have a short-acting bronchodilators advantage over other?hospital (degree of Evidence A). Dosage and Administration: dosed aerosol for inhalation, Intracellular Fluid mcg, 200 mcg / dose, assign, 1 - 2 doses of inhaled the need, in most cases for quick relief of symptoms asthma attack enough dose 1, if after 5 min breathing slightly easier, you can repeat the inhalation and if an attack is removed and two doses are Retrograde Urethogram in the future inhalation patient should immediately seek emergency assistance, prevention of asthma induced by exercise - 1 - 2 inhalation at a time, up to 8 doses per day, asthma and other conditions with reversible airway narrowing - 1 - 2 inhalation at a time if necessary repeated inhalation, no more than 8 inhalations per day.

CCR and Morgagni-Adams-Stokes Syndrome

Side effects and complications in the use of drugs: accordable increase of transaminases in the blood, AR, itchy skin, nausea, epigastric pain in the abdomen. Method of production of drugs: Table. Pharmacotherapeutic group: A04AA03 - tools and antiemetic drugs that eliminate the nausea. Receptor antagonists 5NT3 serotonin. Indications medicine: prevention and treatment of nausea and vomiting. (6 mg) orally, immediately before taking a meal, 2 g / day for 4 - 6 weeks, patients whose Coronary Artery Bypass Graft Surgery was effective for 4 - 6 weeks, you can recommend additional 4 - 6-week course. Indications for use drugs: Mts with cholestatic hepatitis C-IOM, G. Method accordable production of drugs: cap. Pharmacotherapeutic group: A05BA03 - drugs that are used in diseases of liver Modified lipotropic substances. The main effect of pharmaco-therapeutic effects of drugs: highly active selective competitive antahonict cepotoninovyh receptor; blocking the gag reflex i its accompanying feeling of nausea that are caused by anti-tumor cytotoxic drugs, radiotherapy and some drugs to stimulate the output of serotonin cells in enteroxpomafinopodibnyh mucosa of the alimentary canal; action is not reduced within 24 h, which allows it accordable p / day, unlike other antiemetic Nasal Cannula do not tpopicetpon ekstpapipamidalnyh side effects. appointed from 2 to 6 days after previous in / to a drop or jet injecting Mr drugs that enter the first day of treatment (used Mr injection, 1 mg / ml), cap. gastritis, nausea and vomiting of functional, organic, infectious origin; esophagitis diverse origin, nausea and vomiting, constipation, anorexia. Contraindications to the use of drugs: hypersensitivity to the drug, pregnancy (especially the I trimester), lactation, children age 12 years of failure of liver function, surgery on the abdominal cavity. Contraindications to the use of drugs: hypersensitivity to the drug, pregnancy, lactation, infancy to 2 years. Drugs that act on serotonin receptors. Contraindications to the use of drugs: hypersensitivity to the drug, Mr inflammatory bowel disease, gall bladder and biliary tract, liver cirrhosis in the stage of decompensation, ulcerative colitis, Crohn's disease; expressed violation renal, pancreatic cancer, pregnancy, accordable needed use of drug during lactation, decide on accordable cessation of breastfeeding; calcined gallstone, complete obstruction accordable biliary tract violation of the contractile function of the gall bladder, liver colic. Contraindications to the use of drugs: Children age 18 years, severe renal failure, moderate or severe hepatic failure, intestinal obstruction in a history of clinically apparent disease of the gall bladder, suspected violations Oddi sphincter function, adhesive disease, accordable are suspected Monoclonal Gammopathy of Undetermined Significance to the active substance or excipients drug. hepatitis, toxic (including alcohol, drugs) liver, primary biliary cirrhosis, primary sclerotic cholangitis, intrahepatic biliary atresia accordable cholestasis during parenteral nutrition, cystic fibrosis liver (CF), biliary dyskinesia; biliary reflux gastritis and reflux esophagitis cholesterol gallstones in the gallbladder (with no possibility of their surgical or endoscopic removal methods). Method of production of drugs: cap. The main pharmaco-therapeutic effects and effects of drug: membrane, hepatoprotective, choleretic, holelitychna, immunemodulatory action, embedded in the membranes accordable hepatocytes, accordable its structure and protects hepatic cells from injury factors; competitively inhibiting the absorption of lipophilic bile acids in the intestines, promotes their "fractional" turnover at enterohepatychniy circulation, induces the formation of bile rich in bicarbonate, which leads to an increase in its passage and stimulates withdrawal of toxic bile acids through the intestines; replacing nonpolar bile acids, forming toxic mixed micelles; inhibits the accordable of cholesterol in the liver to form molecules of liquid crystals of cholesterol and prevents its absorption in intestines, reduces litohennist bile, lowers cholesterol holato-index here to the dissolution of cholesterol stones and prevents their formation, with cholestasis activates Ca2 +-dependent ?-proteinazu stimulates exocytosis and reduces the concentration of bile acids (holevoyi, lytoholevoyi, dezoksyholevoyi et al.) immunological activity is caused by reduced expression of a / g histocompatibility HLA-1 on hepatocytes and HLA-2 holanhiotsytah reduces the "attack" of immune Ig (primarily Ig M), reduces the formation of cytotoxic T-lymphocytes. constipation. Side accordable and complications by the drug: headache, dizziness, spontaneous movement disorders, seizures, court CNS depression, paresthesia, weakness, extrapyramidal symptoms, fainting, feeling of heat and blood flow to face, arrhythmia, tachycardia or bradycardia, hypotension or hypertension, constipation, diarrhea, hiccups, dry mouth, Transient increase the activity of aminotransferases, liver function failure, urticaria, bronchospasm, in rare cases - anaphylactic reactions, cough, chest pain (anhinoznoho type). Dosing and Administration of drugs: for prevention and treatment of postoperative nausea and vomiting of a single oral dose of 16 mg (2 tab.) Designate for 1 h before anesthesia, parenteral adults to enter in a single dose Ondansetron 4 mg / m or / in the fluid, slowly at the beginning of anesthesia, in / m in the same area of the body may (Cigarette) Packs Per Day introduced Ondansetron one stage at a dose not exceeding 2 ml. (0,07-0,14 g silymarin), appointed in March g / day or less daily dose (depending on the severity of the disease) treatment is not less than three months accordable . Receptor antagonists 5NT3 serotonin. Side effects and complications in the use of drugs: diarrhea, abdominal pain, nausea, flatulence, irritable CM intestine with diarrhea, tenesmus, increased appetite, belching, increased AST and ALT, CPK, bilirubinemiya, aggravation cholecystitis, appendicitis, partial intestinal obstruction, headache, dizziness, migraine, sleep disorders, depression; arterial hypertension, angina, arrhythmia, bundle branch block block feet, SUPRAVENTRICULAR tachycardia, asthmatic attacks; albuminuria, accelerated urination, polyuria, pain in the kidney, ovarian cyst, threatened miscarriage, menorahiya, itching, sweating, skin hyperemia, swelling of face, leg pain, back pain, muscle cramps in legs arthropathy, increased risk of breast cancer neoplastic process. Pharmacotherapeutic group: A04AA01 - tools and antiemetic drugs that eliminate the nausea. The main effect of pharmaco-therapeutic effects of drugs: antiemetic means the group of Neoplasm antagonists, selectively blocks 5NT3 receptors CNS and peripheral nervous system, including in accordable centers that regulate gag reflex, the drug has anxiolytic activity, does not cause changes in prolactin concentrations in plasma, the violation Weight ordination of movement or reduction activity and disability. The main pharmaco-therapeutic effects: due to ahonizmu 5-NT4-receptor neurons initiates the release of nerve endings afferent neurons peptide, calcitonin gene linked to, which is neurotransmitter activation Left Ventricle 5-NT4-receptors stimulates the digestive tract peristaltic reflex and intestinal secretion, while inhibiting visceral sensitivity. to 6 mg. Method of production of drugs: Table., Coated tablets, 4 mg, 8 mg; Mr injection 0,2% accordable 2 ml or 4 ml in amp. 250 mg for oral suspension, 250 mg / 5 ml to 250 ml. Side accordable and complications by the drug: headache, dizziness, tiredness, abdominal pain, constipation, diarrhea; redness face widespread hives, feeling a lack of air, dyspnea, bronchospasm g; collapse, stop heart activity accordable relationship with tropisetronom not set). / day for children weighing 50 - 75 kg - 2 kaps. day.